We create molecules that matter in the lives of patients. Every day, our staff of around 400 comes to work with a youthful exuberance for new discoveries. We are idealistic entrepreneurs whose goal is to go beyond the current standard of care to meet the unmet needs of patients suffering from cancers and autoimmune diseases. Driven to improve patients’ lives, Byondis is an independent, privately held, clinical stage biopharmaceutical company creating innovative precision medicines targeting intractable cancers and autoimmune diseases.